Despite the fact that polymorphisms of the ABC transporter genes cannot directly affect the effectiveness of chemotherapy and the survival of patients with breast cancer, genetic variability can affect the positive and negative regulation of the activity of these genes. Here, ABCG2 is linked to breast cancer.